Annual Current Assets
$519.82 M
+$175.56 M+50.99%
December 31, 2023
Summary
- As of February 7, 2025, ANIP annual total current assets is $519.82 million, with the most recent change of +$175.56 million (+50.99%) on December 31, 2023.
- During the last 3 years, ANIP annual current assets has risen by +$349.50 million (+205.20%).
- ANIP annual current assets is now at all-time high.
Performance
ANIP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$521.30 M
-$34.16 M-6.15%
September 30, 2024
Summary
- As of February 7, 2025, ANIP quarterly total current assets is $521.30 million, with the most recent change of -$34.16 million (-6.15%) on September 30, 2024.
- Over the past year, ANIP quarterly current assets has increased by +$24.08 million (+4.84%).
- ANIP quarterly current assets is now -6.15% below its all-time high of $555.46 million, reached on June 30, 2024.
Performance
ANIP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ANIP Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +51.0% | +4.8% |
3 y3 years | +205.2% | +42.9% |
5 y5 years | +240.0% | +228.6% |
ANIP Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +61.5% | -6.2% | +73.0% |
5 y | 5-year | at high | +205.2% | -6.2% | +233.0% |
alltime | all time | at high | >+9999.0% | -6.2% | >+9999.0% |
ANI Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $521.30 M(-6.2%) |
Jun 2024 | - | $555.46 M(+2.8%) |
Mar 2024 | - | $540.56 M(+4.0%) |
Dec 2023 | $384.61 M(-7.5%) | $519.82 M(+4.5%) |
Sep 2023 | - | $497.22 M(+8.3%) |
Jun 2023 | - | $459.31 M(+25.9%) |
Mar 2023 | - | $364.75 M(+6.0%) |
Dec 2022 | $415.83 M(-7.6%) | $344.26 M(+11.3%) |
Sep 2022 | - | $309.38 M(-4.0%) |
Jun 2022 | - | $322.40 M(+7.0%) |
Mar 2022 | - | $301.40 M(-6.3%) |
Dec 2021 | $449.82 M(+54.6%) | $321.77 M(+68.1%) |
Sep 2021 | - | $191.38 M(-0.2%) |
Jun 2021 | - | $191.80 M(+4.9%) |
Mar 2021 | - | $182.80 M(+7.3%) |
Dec 2020 | $290.87 M(+8.1%) | $170.32 M(+2.7%) |
Sep 2020 | - | $165.82 M(+5.9%) |
Jun 2020 | - | $156.54 M(-1.3%) |
Mar 2020 | - | $158.66 M(-15.5%) |
Dec 2019 | $269.09 M(-3.1%) | $187.69 M(+2.9%) |
Sep 2019 | - | $182.39 M(+8.0%) |
Jun 2019 | - | $168.91 M(+11.2%) |
Mar 2019 | - | $151.83 M(-0.7%) |
Dec 2018 | $277.73 M(-1.0%) | $152.88 M(-2.5%) |
Sep 2018 | - | $156.79 M(+2.9%) |
Jun 2018 | - | $152.37 M(+6.3%) |
Mar 2018 | - | $143.39 M(+9.0%) |
Dec 2017 | $280.53 M(+27.6%) | $131.60 M(+4.8%) |
Sep 2017 | - | $125.58 M(+11.3%) |
Jun 2017 | - | $112.86 M(+5.5%) |
Mar 2017 | - | $106.98 M(+3.9%) |
Dec 2016 | $219.86 M(+137.2%) | $103.01 M(+7.9%) |
Sep 2016 | - | $95.47 M(+19.6%) |
Jun 2016 | - | $79.82 M(-31.5%) |
Mar 2016 | - | $116.55 M(-39.5%) |
Dec 2015 | $92.68 M(+43.5%) | $192.58 M(-2.5%) |
Sep 2015 | - | $197.52 M(-5.5%) |
Jun 2015 | - | $208.95 M(+2.9%) |
Mar 2015 | - | $202.99 M(+4.1%) |
Dec 2014 | $64.57 M(+284.7%) | $194.99 M(+238.7%) |
Sep 2014 | - | $57.56 M(-14.3%) |
Jun 2014 | - | $67.16 M(-1.1%) |
Mar 2014 | - | $67.94 M(+145.1%) |
Dec 2013 | $16.78 M(+366.7%) | $27.72 M(+6.2%) |
Sep 2013 | - | $26.09 M(+8.2%) |
Jun 2013 | - | $24.12 M(-24.5%) |
Mar 2013 | - | $31.93 M(-9.2%) |
Dec 2012 | $3.60 M | $35.17 M(-8.8%) |
Sep 2012 | - | $38.58 M(-10.1%) |
Jun 2012 | - | $42.93 M(-14.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $50.19 M(-13.5%) |
Dec 2011 | $4.35 M(+5.1%) | $58.03 M(-17.7%) |
Sep 2011 | - | $70.54 M(+85.0%) |
Jun 2011 | - | $38.14 M(-27.3%) |
Mar 2011 | - | $52.49 M(+29.2%) |
Dec 2010 | $4.14 M(-17.6%) | $40.63 M(+10.8%) |
Sep 2010 | - | $36.68 M(-22.5%) |
Jun 2010 | - | $47.32 M(+11.5%) |
Mar 2010 | - | $42.45 M(+35.2%) |
Dec 2009 | $5.03 M(+215.7%) | $31.41 M(+120.9%) |
Sep 2009 | - | $14.22 M(+83.9%) |
Jun 2009 | - | $7.73 M(-33.6%) |
Mar 2009 | - | $11.65 M(-27.6%) |
Dec 2008 | $1.59 M(+579.3%) | $16.09 M(-13.3%) |
Sep 2008 | - | $18.55 M(-20.9%) |
Jun 2008 | - | $23.45 M(-16.1%) |
Mar 2008 | - | $27.94 M(-9.9%) |
Dec 2007 | $234.40 K(+44.3%) | $31.01 M(-7.0%) |
Sep 2007 | - | $33.35 M(-4.9%) |
Jun 2007 | - | $35.07 M(+85.4%) |
Mar 2007 | - | $18.92 M(-14.8%) |
Dec 2006 | $162.40 K(-28.6%) | $22.21 M(+110.7%) |
Sep 2006 | - | $10.54 M(+123.6%) |
Jun 2006 | - | $4.71 M(-35.3%) |
Mar 2006 | - | $7.28 M(-22.1%) |
Dec 2005 | $227.60 K(-8.6%) | $9.35 M(-11.5%) |
Sep 2005 | - | $10.57 M(-13.8%) |
Jun 2005 | - | $12.25 M(-18.1%) |
Mar 2005 | - | $14.95 M(-14.9%) |
Dec 2004 | $249.10 K(+0.5%) | $17.58 M(-15.6%) |
Sep 2004 | - | $20.83 M(-9.8%) |
Jun 2004 | - | $23.09 M(+174.3%) |
Mar 2004 | - | $8.42 M(-9.7%) |
Dec 2003 | $247.80 K(-25.3%) | $9.32 M(-12.4%) |
Sep 2003 | - | $10.63 M(+333.1%) |
Jun 2003 | - | $2.45 M(-32.3%) |
Mar 2003 | - | $3.63 M(-34.7%) |
Dec 2002 | $331.90 K(-13.8%) | $5.55 M(+2.2%) |
Sep 2002 | - | $5.43 M(+205.6%) |
Jun 2002 | - | $1.78 M(-45.3%) |
Mar 2002 | - | $3.25 M(-29.3%) |
Dec 2001 | $385.00 K(-1.5%) | $4.59 M(-24.6%) |
Sep 2001 | - | $6.09 M(+25.8%) |
Jun 2001 | - | $4.85 M(-8.0%) |
Mar 2001 | - | $5.27 M(+96.9%) |
Dec 2000 | $390.80 K(-12.4%) | $2.68 M(-19.4%) |
Sep 2000 | - | $3.32 M(-2.5%) |
Jun 2000 | - | $3.41 M(-29.9%) |
Mar 2000 | - | $4.86 M |
Dec 1999 | $446.10 K(-16.3%) | - |
Dec 1998 | $532.80 K | - |
FAQ
- What is ANI Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual current assets year-on-year change?
- What is ANI Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly current assets year-on-year change?
What is ANI Pharmaceuticals annual total current assets?
The current annual current assets of ANIP is $519.82 M
What is the all time high annual current assets for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total current assets is $519.82 M
What is ANI Pharmaceuticals annual current assets year-on-year change?
Over the past year, ANIP annual total current assets has changed by +$175.56 M (+50.99%)
What is ANI Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ANIP is $521.30 M
What is the all time high quarterly current assets for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total current assets is $555.46 M
What is ANI Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ANIP quarterly total current assets has changed by +$24.08 M (+4.84%)